Avid Bioservices(CDMO)

Search documents
Avid Bioservices(CDMO) - 2019 Q4 - Earnings Call Transcript
2019-06-27 23:50
Avid Bioservices, Inc. (NASDAQ:CDMO) Q4 2019 Results Conference Call June 27, 2019 4:30 PM ET Company Participants Tim Brons - Investor Relations Rick Hancock - Interim President and CEO Dan Hart - Chief Financial Officer Tracy Kinjerski - Vice President of Business Operations Conference Call Participants Joe Pantginis - H.C. Wainwright Paul Knight - Janney Montgomery Steve Schwartz - First Analyst Operator Good day, ladies and gentlemen. And welcome to the Avid Bioservices' Fourth Quarter and Year-End 2019 ...
Avid Bioservices(CDMO) - 2019 Q4 - Annual Report
2019-06-27 20:58
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-32839 AVID BIOSERVICES, INC. (Exact name of Registrant as specified in its charter) Delaware ...
Avid Bioservices(CDMO) - 2019 Q3 - Earnings Call Transcript
2019-03-12 00:38
Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2019 Results Earnings Conference Call March 11, 2019 4:30 PM ET Company Participants Tim Brons - Investor Relations Roger Lias - President and Chief Executive Officer Daniel Hart - Chief Financial Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Paul Knight - Janney Montgomery Steven Schwartz - First Analyst Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices’ Third Quarter 2019 Financial Results Conference Call. At this ...
Avid Bioservices(CDMO) - 2019 Q3 - Quarterly Report
2019-03-11 20:49
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-32839 AVID BIOSERVICES, INC. (Exact name of Registrant as specified in its charter) De ...